Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 19/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21118440 | 1.00 | STING1 (0.64) | STING1 | |
| SCHEMBL23635842 | 1.00 | STING1 (0.64) | STING1 | |
| SCHEMBL18937434 | 0.91 | STING1 (0.77) | STING1 | |
| SCHEMBL23477356 | 0.91 | STING1 (0.77) | STING1 | |
| SCHEMBL25854717 | 0.90 | STING1 (0.75) | STING1 | |
| SCHEMBL18822959 | 0.90 | STING1 (0.75) | STING1 | |
| SCHEMBL23476968 | 0.89 | STING1 (0.65) | STING1 | |
| SCHEMBL23477418 | 0.89 | STING1 (0.65) | STING1 | |
| SCHEMBL23799805 | 0.89 | STING1 (0.56) | STING1 | |
| SCHEMBL23618667 | 0.88 | STING1 (0.75) | STING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211815-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | CHINOOK THERAPEUTICS, INC. | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211815-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | STING1, IL15RA, IL15 | STING1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.